A Trial of Thalidomide and Capecitabine in Metastatic Renal Cell Carcinoma
This study has been completed.
Sponsor:
Stanford University
Collaborator:
Celgene Corporation
Information provided by:
Stanford University
ClinicalTrials.gov Identifier:
NCT00226980
First received: September 13, 2005
Last updated: April 10, 2009
Last verified: April 2009
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | July 2006 |
| Primary Completion Date: | July 2005 (Final data collection date for primary outcome measure) |